3-D MatrixDMTRF 55 FCF Margin % is 0.00% as of Jan. 2026. GuruFocus rates DMTRF with a GF Score™ of 55/100 and a GF Value™ of $2.15 (Fairly Valued). The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, 3-D Matrix ranks better than 58.9% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. 3-D Matrix's Free Cash Flow for the
three
months ended in Jan. 2026 was $0.00 Mil. 3-D Matrix's Revenue for the
three
months ended in Jan. 2026 was $16.21 Mil. Therefore, 3-D Matrix's FCF Margin % for the quarter that ended in Jan. 2026 was 0.00%.
The historical rank and industry rank for 3-D Matrix's FCF Margin % or its related term are showing as below:
DMTRF'
s FCF Margin % Range Over the Past 10 Years
Min: -896.08 Med: -254.55 Max: 3.39
Current: 3.28
During the past 13 years, the highest FCF Margin % of 3-D Matrix was 3.39%. The lowest was -896.08%. And the median was -254.55%.
DMTRF's FCF Margin % is ranked better than 58.9% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs DMTRF: 3.28
3-D Matrix FCF Margin % Related Terms
3-D Matrix FCF Margin % Historical Data
* Premium members only.
The historical data trend for 3-D Matrix's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, 3-D Matrix's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
3-D Matrix FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 3-D Matrix's FCF Margin % distribution charts can be found below:
* The bar in red indicates where 3-D Matrix's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
3-D Matrix (DMTRF) has a FCF Margin % of 0.00% as of Jan. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on 3-D Matrix and its competitors. According to the industry distribution chart, 3-D Matrix ranks #335 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 41.1%.
Is 3-D Matrix's FCF Margin % too high?
3-D Matrix's current FCF Margin % is 0.00%. Based on the distribution chart, 3-D Matrix ranks #335 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, 3-D Matrix has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does 3-D Matrix's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, 3-D Matrix ranks #335 out of 815 companies for FCF Margin %. This puts 3-D Matrix in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on 3-D Matrix and its competitors. 3-D Matrix's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3-D Matrix stock overvalued right now?
Based on GuruFocus' analysis, 3-D Matrix (DMTRF) is currently considered Fairly Valued. The stock's GF Value™ is $2.15, compared to a current price of $2.25 — trading 4.7% above its estimated fair value. The current FCF Margin % is 0.00%. 3-D Matrix's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For 3-D Matrix (DMTRF), the current FCF Margin % is 0.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 3-D Matrix (DMTRF) Overvalued in 2026?
Based on GuruFocus' analysis, 3-D Matrix stock appears to be overvalued.
The current stock price of $2.25 is trading 4.7% above its estimated GF Value™ of $2.15.
GuruFocus considers 3-D Matrix to be Fairly Valued.
Key valuation signals for DMTRF:
FCF Margin %: 0.00%
GF Value™: $2.15 vs. price of $2.25 (4.7% above fair value)
No single metric tells the full story. See the DMTRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
3-D Matrix Ltd is engaged in the research, development, manufacture, and sale of medical devices based on the self-assembling peptide technology. Its products include PuraMatrix, High Concentration PuraMatrix, Modified Peptide and GMP Grade PuraMatrix.
55GF Score
Get the complete analysis for DMTRF
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DMTRF has been successfully added to your 
